Life Sciences

Partner, Patent Attorney

Most of Emily’s work is in the Life Sciences sector, with a focus on biotechnology. Emily has extensive experience drafting and prosecuting patent applications and is particularly experienced at handling large global portfolios and providing strategic advice to clients in line with their commercial interests. This also means that she has experience prosecuting applications not just at the European Patent Office, but worldwide. Emily has a sizeable oppositions and appeals practice and she is extremely experienced at handling hearings before the EPO.

Areas of Expertise

Antibody therapeutics, particularly for oncology and treating inflammatory diseases Transgenic mouse technology Diagnostic methods and personalised medicine

In the UK and Europe, Emily’s clients are biopharma companies, multinational biotech corporations, as well as biotech start-ups, research charities and universities.  She also handles work for US attorney firms, as well as directly for some multinational biotech corporations based in the US.

mily has an M.Sci. degree in Natural Sciences (specialising in Biochemistry) from the University of Cambridge.  She also has a Ph.D. in Biochemistry from the University of Cambridge, focussing on the development of an anti-angiogenic gene therapy for the treatment of cancer.  Emily joined Mewburn Ellis LLP in 2005, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 2009.  She joined the partnership in 2013.

In 2010, she spent three months on secondment to a US patent attorney firm in Boston, developing expertise in the US life sciences and patent sectors.  Emily has presented many seminars on European patent law practice to US patent attorneys, including at AIPLA.  She has also written for the Boston Patent Law Association newsletter.